Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Kudzu

BotanicalBest with a meal

Useful mainly for adults who want to reduce alcohol consumption during a drinking session.

Quick decision guide

May help most

Adults who want to reduce alcohol consumption during a drinking session

Common dosing range

1,000–3,000 mg/day root extract (standardized to puerarin); 300–1,000 mg/day for menopausal symptoms

When to expect effects

Hours (alcohol reduction, acute); Weeks to months (menopausal symptoms)

Watch out for

Estrogenic activity — avoid in hormone-sensitive conditions (breast cancer, endometriosis, uterine fibroids)

What is it

Kudzu (Pueraria lobata, also known as ge gen in Traditional Chinese Medicine) is a perennial vine native to East Asia. Its root has been used for over 2,000 years in TCM and is studied today primarily for menopause symptoms and alcohol use reduction.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You want to drink less per session and prefer a non-aversive approach (no nausea or sickness)

You have menopausal hot flashes and cannot use conventional hormone therapy, seeking a plant-based option

Probably skip if…

You have a hormone-sensitive cancer or condition (breast cancer, endometriosis, uterine fibroids)

You are pregnant or breastfeeding — insufficient safety data

You take hormone therapy or tamoxifen — potential estrogenic interaction

You need treatment for alcohol use disorder — kudzu is not a replacement for evidence-based treatment

Evidence at a glance

Goal	Effect	Best fit	Time
alcohol consumption reduction Good Evidence	Approximately 25–50% reduction in drinks consumed per session in controlled studies	Non-dependent heavy drinkers seeking to reduce session intake; males and females both studied	Hours (acute, same session)
menopausal hot flashes Limited Evidence	Modest reduction in hot flash frequency in some trials	Postmenopausal women with hot flashes who cannot or choose not to use HRT	Weeks to months
cardiovascular biomarkers Limited Evidence	Small reductions in blood pressure and improvements in endothelial function in limited studies	Adults with mildly elevated blood pressure	Weeks to months

alcohol consumption reduction

Good Evidence

Effect: Approximately 25–50% reduction in drinks consumed per session in controlled studies
Best fit: Non-dependent heavy drinkers seeking to reduce session intake; males and females both studied
Time: Hours (acute, same session)

menopausal hot flashes

Limited Evidence

Effect: Modest reduction in hot flash frequency in some trials
Best fit: Postmenopausal women with hot flashes who cannot or choose not to use HRT
Time: Weeks to months

cardiovascular biomarkers

Limited Evidence

Effect: Small reductions in blood pressure and improvements in endothelial function in limited studies
Best fit: Adults with mildly elevated blood pressure
Time: Weeks to months

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

alcohol consumption reduction

Supplement benefit

Good Evidence

Multiple RCTs have shown that kudzu extract (standardized for puerarin) administered before a drinking session significantly reduces the number of beers consumed — typically by 25–50% — without causing aversive reactions. The mechanism may involve altered alcohol metabolism or central reward processing. Effects are on drinking volume, not craving or abstinence.

Effect size

Approximately 25–50% reduction in drinks consumed per session in controlled studies

Time to effect

Hours (acute, same session)

Best fit

Non-dependent heavy drinkers seeking to reduce session intake; males and females both studied

Less likely

People with severe alcohol use disorder — this is not a primary treatment

Bottom line: Best-evidenced use for kudzu — reduces drinks per session without discomfort; not a substitute for alcohol use disorder treatment.

SourcePenetar et al., 2015 — PMC Lukas et al., 2013 — PMC

menopausal hot flashes

Supplement benefit

Limited Evidence

Kudzu isoflavones bind preferentially to estrogen receptor beta and may modestly attenuate vasomotor symptoms. Small RCTs show inconsistent results for hot flash frequency and severity. Evidence is not strong enough to recommend as a primary therapy.

Effect size

Modest reduction in hot flash frequency in some trials

Time to effect

Weeks to months

Best fit

Postmenopausal women with hot flashes who cannot or choose not to use HRT

Less likely

Women with hormone-sensitive conditions — estrogenic activity is a concern

Bottom line: Plausible mechanism, inconsistent evidence; appropriate only for women who have been counseled on the estrogenic risk.

Evidence is mixed

Some trials show modest hot flash reduction; others show no significant benefit versus placebo; heterogeneity in formulations and populations limits conclusions.

SourceKim et al., 2020 — PMC· conflicting Lamlertkittikul et al., 2004 — PubMed· conflicting

SourceKim et al., 2020 — PMC Lamlertkittikul et al., 2004 — PubMed

cardiovascular biomarkers

Biomarker support

Limited Evidence

Small trials report modest blood pressure lowering and improved endothelial function with kudzu root extract, attributed primarily to puerarin. Evidence is preliminary, study sizes are small, and clinical significance of the biomarker changes is unclear.

Effect size

Small reductions in blood pressure and improvements in endothelial function in limited studies

Time to effect

Weeks to months

Best fit

Adults with mildly elevated blood pressure

Bottom line: Preliminary cardiovascular biomarker signal; insufficient evidence to recommend for blood pressure management.

SourceVerma et al., 2012 — PubMed

How it works

Kudzu root contains isoflavones (puerarin, daidzein, daidzin, genistein) that have weak estrogen-like activity, binding more selectively to estrogen receptor beta than alpha. This selectivity may underlie kudzu's traditional use for menopausal hot flashes and may have a different safety profile than stronger estrogenic compounds. The most distinctive research on kudzu involves alcohol reduction. Several human trials have shown that kudzu extract (typically standardized for puerarin) reduces the number of beers consumed during a drinking session by approximately 25-50%, without affecting craving or causing aversive reactions. The mechanism may involve altered alcohol metabolism (acetaldehyde accumulation) or central effects on reward processing. Kudzu has also been studied for cardiovascular effects (modest blood pressure lowering, potential effects on endothelial function), bone health, and as a treatment for migraines and cluster headaches with mixed evidence.

How to take it

1. Typical dose

1,000–3,000 mg/day for alcohol reduction; 300–1,000 mg/day for menopausal symptoms

2. Timing

For alcohol use reduction: 1–2 hours before anticipated drinking; for menopausal symptoms: divided doses with meals

3. With food

With food

4. How long to try

Alcohol reduction: per-occasion acute use or short trial; menopausal symptoms: 8–12 week trial

What to track

Number of drinks consumed per session (alcohol use goal)

Hot flash frequency and severity (menopause goal)

Blood pressure if on antihypertensives

GI tolerance

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Kudzu root extract standardized to puerarin

Look for products standardized to 40% puerarin for consistency with research.

Most studied form; concentration of active.

Whole root powder

Used in TCM teas and decoctions.

Lower active concentration; traditional form.

Puerarin (isolated)

IV puerarin is used clinically in China for cardiovascular conditions.

Pure active; used in research and Chinese pharmaceuticals.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

GI upsetHeadacheDizziness

Who should avoid it

Women with hormone-sensitive cancers (breast cancer, ovarian cancer)
SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs
People with endometriosis or uterine fibroids
SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs
Pregnant and breastfeeding women
SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs

Pregnancy & breastfeeding

Insufficient safety data — avoid during pregnancy and breastfeeding.

SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs

Interactions

hormone therapies (estrogens, tamoxifen)Moderate

Estrogenic isoflavones may compete with or potentiate hormone therapies; unpredictable interaction

SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs

antihypertensive medicationsModerate

Additive blood pressure lowering possible; monitor blood pressure

SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs

diabetes medicationsMinor

Theoretical blood glucose lowering effect; monitor glucose

SourceMemorial Sloan Kettering — Kudzu — MSKCC About Herbs

Food sources

Food	Amount	%DV
Kudzu starch	1 tbsp	—

Kudzu starch

Amount: 1 tbsp
%DV: —

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Standardized puerarin percentage stated (commonly 40%)

Total puerarin dose in mg specified

Ge gen or Pueraria lobata botanical source identified

Be skeptical of…

'Cures alcoholism'

'Safe estrogen replacement'

'Treats alcohol dependence'

'Hormone balancer for all women'

Frequently asked questions

Does kudzu really reduce drinking?⌄

Yes, in controlled studies. Participants drink fewer beers per session without feeling sick or craving less. It doesn't address alcohol use disorder root causes but can be useful as a harm-reduction tool.

How does kudzu compare to other supplements for menopause?⌄

Effects on hot flashes are modest. Soy isoflavones, black cohosh, and red clover have more research; kudzu is a reasonable additional option.

Is kudzu safe to take long-term?⌄

Short-term safety is good; long-term safety data is limited. Periodic breaks and consultation with a healthcare provider for extended use are reasonable.

Will kudzu affect my hormones?⌄

Kudzu has weak estrogenic activity. Generally not a concern for most adults but should be avoided with hormone-sensitive conditions.

References by claim

alcohol consumption reduction

Penetar et al., 2015 — PMC (2015) link

Lukas et al., 2013 — PMC (2013) link

menopausal hot flashes

Kim et al., 2020 — PMC (2020) link

Lamlertkittikul et al., 2004 — PubMed (2004) link

cardiovascular biomarkers

Verma et al., 2012 — PubMed (2012) link

Safety

Memorial Sloan Kettering — Kudzu — MSKCC About Herbs link

Track Kudzu with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.